Neuropsychopharmacology
- Prevention of late-life depression: a framework and prospectus for research7 months ago
- Hair cortisol concentrations as a putative biomarker for suicidal behavior7 months ago
- Effects of electroconvulsive shock on the function, circuitry, and transcriptome of dentate gyrus granule neurons7 months ago
- Hypocretin receptor 1 blockade early in abstinence prevents incubation of cocaine seeking and normalizes dopamine transmission7 months ago
- Whole brain grey matter synaptic terminal density, age and intellectual functioning in schizophrenia: an in vivo [11C]UCB-J positron emission tomography study7 months ago
- Stereoselective, sex-dependent 5-HT2A receptor modulation of cortical plasticity by MDMA in mice7 months ago
- Medial prefrontal-thalamic white matter microstructure is associated with harm avoidance in OCD: a discovery and transdiagnostic replication study8 months ago
Journal of Psychopharmacology
- β-blockers and risk of neuropsychiatric adverse events: An active-comparator restricted disproportionality on the FAERS1 year ago
- Adverse event monitoring, assessment, and reporting in nutraceutical and phytoceutical trials for pediatric neuropsychiatric conditions: A systematic review1 year ago
- A systematic review and narrative summary of the therapeutic potential of classic serotonergic psychedelics for smoking cessation and reduction1 year ago
- Unequal representation? A cross-sectional analysis of age, sex, race, and ethnicity in clinical trials of classic psychedelics1 year ago
- The effect of betahistine on weight-related and metabolic measures in patients with schizophrenia treated with olanzapine and risperidone1 year ago
- Evaluating the impact of cannabis oil for autistic children with and without concomitant medications: Insights from an open-label study1 year ago
- Roles of the 5-HT1A receptor in zebrafish responses to potential threat and in sociality1 year ago
European Neuropsychopharmacology
- Predicting 10-year risk of chronic kidney disease in lithium-treated patients with bipolar disorder: A risk model development and internal cross-validation study1 year ago
- Negative Symptoms in Schizophrenia: The Placebo Effect as a Barrier to Drug Development?1 year ago
- Racial and ethnic diversity in zuranolone and brexanolone clinical trials for postpartum depression: A cross-sectional analysis of ClinicalTrials.gov1 year ago
- Creatine as a treatment for depression: A brain bioenergetics perspective1 year ago
- Frequency, correlates and outcomes of Benzodiazepine use during Cariprazine treatment: A pooled post-hoc analysis from four 6-week, placebo-controlled trials in patients with an acute exacerbation of schizophrenia1 year ago
- Letter to the editor: Premature conclusions on antipsychotic continuation in environmentally conscious psychopharmacotherapy2 years ago
- COSMIN systematic review and meta-analysis of the measurement properties of the PANSS-62 years ago